Polyphenol Benefits for Endometriosis Remained Unproven
A new narrative review found limited clinical evidence supporting the use of polyphenols to treat endometriosis symptoms.
Updated on Oct. 12, 2026 in Nutrition
Live Poll
Do you trust that dietary supplements are effective for treating chronic health conditions?
A review published in Antioxidants concluded that human evidence for the clinical benefits of polyphenols in treating endometriosis is insufficient. Researchers highlighted that current data on efficacy and long-term safety remains inconclusive.
Why it matters
Endometriosis affects 10% of individuals of reproductive age and imposes a $69.4 billion annual economic burden in the U.S. alone. Understanding the true therapeutic potential of dietary supplements is essential for effective patient management.
A 42-day trial found 40 mg/day of resveratrol was not superior to a placebo for pain management. Additionally, the European Food Safety Authority has linked 800 mg/day of epigallocatechin-3-gallate to increased markers of liver injury.
The players
European Food Safety Authority
This agency provides scientific advice and communication on risks associated with the food chain in the European Union.
Antioxidants
This is a peer-reviewed scientific journal that focuses on the study of antioxidants in health, food, and technology.
The details
The review analyzed databases including PubMed and Scopus through May 2026 to assess how polyphenols influence inflammatory pathways and cell signaling in preclinical models. While laboratory research indicates biological activity, the authors noted that human studies are too limited to confirm clinical benefits.
Timeline
The European Food Safety Authority issued a safety opinion on green tea catechins in 2018.
The narrative review conducted its database searches through May 2026.
The article detailing these findings was published on October 12, 2026.
The Big Picture
This study aligns with the safety thresholds established by the European Food Safety Authority safety opinion on green tea catechins. The findings emphasize that clinical guidance must remain cautious until more robust, standardized trials are conducted.
Patients should be aware that supplements combining quercetin, turmeric, or other polyphenols lack standardized, long-term safety data for endometriosis treatment. Individuals are advised to consult with healthcare providers before starting new regimens due to potential risks like liver injury.
The takeaway
Patients should approach dietary supplements for endometriosis with caution given the current lack of high-quality human trial evidence. It is recommended that individuals prioritize treatments with established clinical efficacy and talk to a doctor regarding specific health goals.
Further reading
For more information on the intersection of diet and health, visit the Nutrition section.
Source note: This article includes information reported by Ajmc.
Live Poll
Do you trust that dietary supplements are effective for treating chronic health conditions?
